Pregnancy

NIPT: What This Blood Test Screens For

Save

NIPT is a screening blood test, usually from 10 weeks, that estimates the chance of trisomy 21, 18, or 13 by analyzing placental DNA in the pregnant person's blood. It is highly sensitive but not diagnostic: a higher-chance result is confirmed with diagnostic testing such as CVS or amniocentesis.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What does NIPT actually screen for?

NIPT looks mainly for the three most common autosomal trisomies - an extra copy of chromosome 21 (Down syndrome), 18 (Edwards syndrome), or 13 (Patau syndrome) 1. Most laboratories also report the chromosomes that determine sex, and many offer add-ons for sex-chromosome differences, though those add-ons perform less well. According to NICE antenatal-care guidance, the test works by measuring cell-free DNA - short fragments shed mainly by the placenta - in a sample drawn from your arm 1. Because it needs enough fetal fraction to read, most programs schedule it from about 10 weeks 1. Some expanded panels advertise rare microdeletions, but professional guidance is more cautious about those.

How accurate is NIPT, and what are its limits?

NIPT detects the large majority of Down syndrome pregnancies and has a low false-positive rate, which is why it outperforms older blood-marker screens 1. Accuracy is not the same as certainty, though. Because the DNA it reads comes from the placenta rather than the fetus directly, a placenta whose cells differ from the baby's can produce a false signal. A no-result can also happen when the fetal fraction is too low, which is more common before 10 weeks or at higher body weight. According to prenatal-care guidance, no screening test can rule a condition in or out - that is the job of diagnostic testing 2.

How does NIPT compare with other prenatal tests?

Prenatal screening comes in layers, and NIPT is one of the more sensitive options. A first-trimester combined screen pairs a nuchal-translucency ultrasound with blood markers between 11 and 14 weeks, while a quad screen uses four blood markers between 14 and 20 weeks 1. NIPT detects the common trisomies more reliably than either, but it screens a narrower list and does not flag neural-tube defects. According to NICE, many programs offer NIPT as a second step after a higher-chance combined or quad result of 1 in 150 or greater 1. Planning ahead at your first prenatal appointment helps you weigh which tests fit your situation 2.

Who might consider NIPT, and when?

NIPT can be offered to anyone who is pregnant, regardless of age or risk level 1. The chance a screen is trying to quantify does rise with maternal age, because the likelihood of a chromosomal difference increases as eggs age 3. Interpretation also shifts across the reproductive lifespan - a teenager's baseline chance differs from that of someone conceiving in their forties, near the perimenopausal transition 3. Discussing options early, alongside genetic testing of embryos for those who used IVF, helps match testing to your priorities 24. Other routine checks, such as gestational diabetes testing, come later in pregnancy, so there is time to plan.

When an NIPT result needs a genetic counselor

A higher-chance NIPT result, an unexplained no-call, or a family history of chromosomal conditions are all good reasons to talk with a genetic counselor or a maternal-fetal medicine specialist 2. These clinicians can explain what your specific result means, walk through diagnostic options such as CVS or amniocentesis, and help you decide what information you actually want. A higher-chance screen is not a diagnosis, and time spent understanding the numbers is rarely wasted 4. Arranging prenatal care early gives room to plan any follow-up testing without pressure. Gale can help you prepare questions for that conversation.

Common questions

A blood test. NIPT analyzes cell-free DNA in a sample drawn from the pregnant person's arm, usually from about 10 weeks. It is sometimes done alongside an ultrasound, but the NIPT result itself comes from the blood, not the scan.

No. NIPT screens for specific chromosomal differences such as trisomy 21, 18, and 13, and it reports fetal sex. It does not detect autism, intellectual ability, or structural defects like heart or spine problems, which are looked for on ultrasound.

Yes. Because the DNA it reads comes mainly from the placenta, results can occasionally be false positives or false negatives, and sometimes there is no result at all. That is why a higher-chance NIPT is confirmed with diagnostic testing rather than treated as final.

No. Prenatal screening is optional. Some people want as much information as possible, others prefer to limit testing, and both choices are valid. A clinician or genetic counselor can help you decide what fits your priorities.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When to check in about a prenatal screening result

  • —A higher-chance or positive NIPT result is a reason to arrange a conversation with a genetic counselor or obstetric clinician before drawing conclusions
  • —An unexplained no-call or failed NIPT result is a reason to ask your clinician about repeat or alternative testing
  • —Vaginal bleeding, cramping, or fluid loss after a diagnostic procedure such as CVS or amniocentesis is a reason to contact your obstetric clinician promptly
  • —Anxiety about a result that interferes with sleep or daily life is a reason to seek support from your clinician

This article is general health education about prenatal screening, not medical advice. Whether and which screening or diagnostic tests are right for your pregnancy is a decision to make with an obstetric clinician, maternal-fetal medicine specialist, or genetic counselor.

References

  1. 1.National Institute for Health and Care Excellence (2024). Antenatal care (NG201). National Institute for Health and Care Excellence (NICE). link ✓Defines the antenatal screening pathway: the combined first-trimester test (nuchal translucency plus blood markers) between 11 and 14 weeks, the quadruple test between 14 and 20 weeks, cell-free DNA (NIPT) offered from about 10 weeks as a further test after a higher-chance result of 1 in 150 or greater, and that screening estimates a chance rather than diagnosing.
  2. 2.Office on Women's Health (U.S. HHS) (2025). Prenatal care. Office on Women's Health (womenshealth.gov), U.S. HHS. link ✓Patient-facing overview that prenatal screening tests are an optional, routine part of prenatal care, that results estimate the chance of a condition, and that a positive screen is followed by diagnostic testing discussed with an obstetric clinician.
  3. 3.American College of Obstetricians and Gynecologists / American Society for Reproductive Medicine (2014). Female age-related fertility decline. Committee Opinion No. 589. Obstetrics & Gynecology. doi:10.1097/01.AOG.0000444440.96486.61 ✓Documents that the risk of fetal chromosomal abnormalities rises with maternal age, the basis for age-related differences in screening probabilities.
  4. 4.American College of Obstetricians and Gynecologists (2019). ACOG Committee Opinion No. 762: Prepregnancy Counseling. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000003013 ✓Prepregnancy and early-pregnancy counseling includes discussing aneuploidy and genetic screening options and referral for genetic counseling.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library